Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cells to replace the optic nerve.

H A Quigley1, D S Iglesia

  • 1Glaucoma Service and the Dana Center for Preventive Ophthalmology, Wilmer Ophthalmological Institute, Johns Hopkins University, School of Medicine, Baltimore MD 21205, USA.

Eye (London, England)
|November 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective loss of pattern discrimination in early glaucoma.

Applied optics·2010
Same author

Effect of cataract on a scotopic sensitivity screening test for glaucoma.

Journal of glaucoma·2009
Same author

The number of people with glaucoma worldwide in 2010 and 2020.

The British journal of ophthalmology·2006
Same author

Parafoveal retinal telangiectasis: light and electron microscopy studies. 1977.

Retina (Philadelphia, Pa.)·2005
Same author

New paradigms in the mechanisms and management of glaucoma.

Eye (London, England)·2004
Same author

Gene therapy for optic nerve disease.

Eye (London, England)·2004
Same journal

Tubing the trabeculectomy: a novel filtration technique.

Eye (London, England)·2026
Same journal

Retinal non-perfusion progression in severe non-proliferative and proliferative diabetic retinopathy over time: INSPIRED study report 2.

Eye (London, England)·2026
Same journal

Macular serpiginous choroiditis versus macular serpiginous-like choroiditis: clinical features, outcomes and prognosis.

Eye (London, England)·2026
Same journal

Association of baseline brain care score with the incidence of age-related eye diseases.

Eye (London, England)·2026
Same journal

A comparative analysis of carbon dioxide versus nitrous oxide as the pressurised gas driving a retinal cryotherapy unit.

Eye (London, England)·2026
Same journal

Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.

Eye (London, England)·2026
See all related articles

New methods aim to replace damaged retinal ganglion cells and optic nerve axons. This research seeks to restore vision for individuals with glaucoma-induced blindness.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Regenerative Medicine

Background:

  • Glaucoma is a leading cause of irreversible blindness.
  • Damage to retinal ganglion cells and their axons in the optic nerve causes vision loss in glaucoma.
  • Current treatments do not restore lost vision.

Purpose of the Study:

  • To explore existing and novel methods for replacing retinal ganglion cells (RGCs) and optic nerve axons.
  • To investigate strategies for re-establishing functional vision in glaucoma patients.

Main Methods:

  • Review of current regenerative approaches for RGCs and optic nerve axons.
  • Discussion of potential future therapeutic strategies.
  • Analysis of methods to promote axonal regeneration and functional recovery.

Related Experiment Videos

Main Results:

  • Identification of promising therapeutic targets and techniques.
  • Evaluation of the feasibility of cell replacement and axonal regeneration strategies.
  • Highlighting the potential for restoring visual function.

Conclusions:

  • Regenerative approaches hold significant promise for treating glaucoma-induced blindness.
  • Further research and development are needed to translate these methods into clinical practice.
  • Restoring vision in glaucoma patients is an achievable long-term goal.